This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Tice, J. A. Articles by Wrensch, M. R. Search for Related Content PubMed PubMed Citation Articles by Tice, J. A. Articles by Wrensch, M. R.

Nipple Aspirate Fluid Cytology and the Gail Model for Breast Cancer Risk Assessment in a Screening Population

¹ Division of General Internal Medicine, Department of Medicine, ² Department of Epidemiology and Biostatistics, and ³ Cancer Center, University of California, San Francisco, San Francisco, California

Requests for reprints: Jeffrey A. Tice, Division of General Internal Medicine, Department of Medicine, University of California, San Francisco, 1701 Divisadero Street, Suite 554, San Francisco, CA 94143-1732. Phone: 415-885-7866; Fax: 415-353-7932. E-mail: jtice{at}medicine.ucsf.edu

Background: Recent guidelines suggest that chemoprevention with tamoxifen may be appropriate for women who have a 5-year risk of breast cancer greater than 1.66% calculated using the Gail model.

Objectives: To determine whether nipple aspirate fluid (NAF) cytology combined with the Gail model provides breast cancer risk assessment that is superior to either method alone.

Methods: Prospective observational cohort of 6,904 asymptomatic women. Breast cancer cases were identified through follow-up with the women and linkage to cancer registries. We used proportional hazards modeling to recalculate the coefficients for the predictor variables used in the Gail model. NAF cytology was added to create a second model. The two models were compared using the concordance statistic (c-statistic).

Results: During 14.6 years of follow-up, 400 women were diagnosed with breast cancer. There were 940 (14%) women with hyperplasia and 109 (1.6%) women with atypical hyperplasia found in NAF. Adding NAF cytology results to the Gail model significantly improved the model fit (P < 0.0001). The c-statistic for the Gail model was 0.62, indicating only modest discriminatory accuracy. Adding NAF cytology to the model increased the c-statistic to 0.64. NAF cytology results had the largest effect on discriminatory accuracy among women in the upper third of Gail model risk. The relative incidence for the highest quintile of risk score compared with the lowest quintile was 7.2 for the Gail model and 8.0 for the model including NAF cytology.

Conclusion: NAF cytology has the potential to improve prediction models of breast cancer incidence, particularly for high-risk women.

This article has been cited by other articles:

				Y. Huang, K. E. Anderson, M. Nagamani, J. J. Grady, and L.-J. W. Lu Dietary Intake of Lactose as a Strong Predictor for Secretor Status of Nipple Aspirate Fluid in Healthy Premenopausal Nonlactating Women Clin. Cancer Res., March 1, 2008; 14(5): 1386 - 1392. [Abstract] [Full Text] [PDF]

				D. Lithgow, A. Nyamathi, D. Elashoff, O. Martinez-Maza, and C. Covington C-reactive Protein in Nipple Aspirate Fluid Associated With Gail Model Factors Biol Res Nurs, October 1, 2007; 9(2): 108 - 116. [Abstract] [PDF]

				C. J. Fabian Is There a Future for Ductal Lavage? Clin. Cancer Res., August 15, 2007; 13(16): 4655 - 4656. [Full Text] [PDF]

				K. Armstrong, E. Moye, S. Williams, J. A. Berlin, and E. E. Reynolds Screening Mammography in Women 40 to 49 Years of Age: A Systematic Review for the American College of Physicians Ann Intern Med, April 3, 2007; 146(7): 516 - 526. [Abstract] [Full Text] [PDF]

				F. Mannello and G. A.M. Tonti Benign Breast Diseases: Classification, Diagnosis, and Management Oncologist, November 1, 2006; 11(10): 1132 - 1134. [Full Text] [PDF]